Table 1 The clinicopathological relevance analysis of TMEM158 expression in patients with gliomas.
Variable | Total | TMEM158 expression | p value | |
|---|---|---|---|---|
High | Low | Â | ||
Age | Â | Â | Â | 0.157 |
 ≤45 years | 19 | 12 | 7 |  |
 >45 years | 33 | 27 | 6 |  |
Gender | Â | Â | Â | 0.510 |
 Male | 26 | 19 | 7 |  |
 Female | 26 | 21 | 5 |  |
WHO grade | Â | Â | Â | 0.003** |
 LGG | 24 | 14 | 10 |  |
 GBM | 28 | 26 | 2 |  |